Date Initiated by Firm |
November 17, 2011 |
Date Posted |
January 11, 2012 |
Recall Status1 |
Terminated 3 on January 09, 2012 |
Recall Number |
Z-0453-2012 |
Recall Event ID |
60481 |
510(K)Number |
K082140 K101879
|
Product Classification |
in vitro diagnostic MRSA - Product Code NQX
|
Product |
Cepheid brand Xpert MRSA/SA-BC US-IVD, an In-vitro diagnostic test kit, Catalog Numbers: GXMRSA/SA-BC-10, Lots Affected: 2803 and 3001;
|
Code Information |
Lots affected: 2803 and 3001 |
Recalling Firm/ Manufacturer |
Cepheid 904 E Caribbean Dr Sunnyvale CA 94089-1189
|
For Additional Information Contact |
Judith A Howard 408-541-4191
|
Manufacturer Reason for Recall |
Cepheid has received reports from some of its customers regarding higher than desired (>5%) rates of invalid results when using lot numbers 2803 and 3001 of the Xpert MRSA/SA BC (blood culture) product.
|
FDA Determined Cause 2 |
Nonconforming Material/Component |
Action |
On 11/17/11, Cepheid issued letters via mail to all its direct consignees, informing them of the affected products and providing instructions on the recall. |
Quantity in Commerce |
1289 |
Distribution |
Product was released for distribution in US. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = NQX and Original Applicant = CEPHEID
|